Factors influencing HPV vaccination willingness among men who have sex with men in China: a structural equation modeling analysis

References

• Han JJ, Beltran TH, Song JW, Klaric J, Choi YS. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013-2014. Jama Oncol. 2017;3(6):810–9. doi:10.1001/jamaoncol.2016.6192.
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Cancer registration statistics, England: first release. 2016. [accessed 2021 Nov 19]. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2016
   Google Scholar
• Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus–Associated cancers — United States, 1999–2015. MMWR Morb Mortal Wkly Rep. 2018;67(33):918–24. doi:10.15585/mmwr.mm6733a2.
   PubMed Web of Science ®Google Scholar
• Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13(5):487–500. doi:10.1016/S1470-2045(12)70080-3.
   PubMed Web of Science ®Google Scholar
• Sonawane K, Suk R, Chiao EY, Chhatwal J, Qiu P, Wilkin T, Nyitray AG, Sikora AG, Deshmukh AA. Oral human papillomavirus infection: differences in prevalence between sexes and concordance with genital human papilloma virus infection, NHANES 2011 to 2014. Ann Intern Med. 2017;167(10):714–24. doi:10.7326/M17-1363.
   PubMed Web of Science ®Google Scholar
• Marra E, Lin C, Clifford GM. Type-Specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis. J Infect Dis. 2019;219(4):590–98. doi:10.1093/infdis/jiy556.
   PubMed Web of Science ®Google Scholar
• Ma X, Wang Q, Ong JJ, Fairley CK, Su S, Peng P, Jing J, Wang L, Soe NN, Cheng F, et al. Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis. Sex Transm Infect. 2018;94(6):434–42. doi:10.1136/sextrans-2017-053412.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lin Y, Gao L, Dai J, Luo G, Li L, Yuan T, Li P, Zhan Y, Gao Y, et al. Human papillomavirus prevalence among men who have sex with men in China: a systematic review and meta-analysis. Eur J Clin Microbiol. 2021;40(7):1357–67. doi:10.1007/s10096-021-04229-y.
   Google Scholar
• Li X, Li M, Yang Y, Zhong X, Feng B, Xin H, Li Z, Jin Q, Gao L. Anal HPV/HIV co-infection among men who have sex with men: a cross-sectional survey from three cities in China. Sci Rep-Uk. 2016:6. doi:10.1038/srep21368.
   PubMed Web of Science ®Google Scholar
• Ming G, Yong-Hong L, Ling-Hua L, Xi-Zi D, Yuan N, Feng L, Feng-Yu H. Prevalence of anal HPV infection among HIV-positive men who have sex with men. J Trop Med. 2019;19:785–88.
   Google Scholar
• Beliakov I, Senina M, Tyulenev Y, Novoselova E, Surovtsev V, Guschin A. The prevalence of high carcinogenic risk of HPV genotypes among HIV-positive and HIV-negative MSM from Russia. Can J Infect Dis Med Microbiol. 2021;2021:1–6. doi:10.1155/2021/6641888.
   Web of Science ®Google Scholar
• World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017;92:241–68.
   PubMedGoogle Scholar
• Centre for Health Protection. Consensus statement on the use of human papillomavirus (HPV) vaccine in prevention of cervical cancer. [ accessed 2021 Nov 19]. https://www.chp.gov.hk/files/pdf/consensus_statement_on_the_use_of_hpv_vaccine_in_prevention_of_cervical_cancer.pdf
   Google Scholar
• Chow EPF, Carter A, Vickers T, Fairley CK, McNulty A, Guy RJ, Regan DG, Grulich AE, Callander D, and Khawar L, et al. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004–18. Lancet Infect Dis. 2021;10(1016/S1473–3099(21)00071–2):1-13.
   Google Scholar
• Petrosky E, Bocchini JJA, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–04
   PubMed Web of Science ®Google Scholar
• Goldstone SE, Giuliano AR, Palefsky JM, Lazcano-Ponce E, Penny ME, Cabello RE, Moreira ED, Baraldi E, Jessen H, and Ferenczy A, et al. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2021:1-13. doi:10.1016/S1473-3099(21)00327-3.
   PubMedGoogle Scholar
• Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Garland SM, Cornall AM, Atchison S, Hocking JS, Bradshaw CS, et al. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study. Lancet Infect Dis. 2021;21:1448–57. doi:10.1016/S1473-3099(20)30687-3.
   PubMed Web of Science ®Google Scholar
• Winer R, Lin J, Querec T, Unger E, Stern J, Rudd J, Golden M, Swanson F, Markowitz L, Meites EJTJ. Effectiveness of human papillomavirus (HPV) vaccination against Penile Hpv infection in men who have sex with men and transgender women. 2021. doi:10.1093/infdis/jiab390.
   Google Scholar
• Díez-Domingo J, Sánchez-Alonso V, Villanueva R, Acedo L, Tuells J. Impact of a gender-neutral HPV vaccination program in men who have sex with men (MSM). Int J Env Res Pub He. 2021;18(3):963. doi:10.3390/ijerph18030963.
   PubMed Web of Science ®Google Scholar
• Ali H, Donovan B, Wand H, Read TRH, Regan DG, Grulich AE, Fairley CK, Guy RJ. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Bmj. 2013;346:f2032. doi:10.1136/bmj.f2032.
   PubMed Web of Science ®Google Scholar
• Tota JE, Giuliano AR, Goldstone SE, Brady D, Alfred S, Alain L, Christine V, and Palefsky JM. Anogenital HPV infection, Seroprevalence, and risk factors for HPV seropositivity among sexually active men enrolled in a Global HPV vaccine trial. Clin Infect Dis. 2021.
   Web of Science ®Google Scholar
• Bogaards JA, Mooij SH, Xiridou M, Schim Van Der Loeff MF, de Sanjosé S. Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach. PLoS Med. 2019;16(3):e1002756. doi:10.1371/journal.pmed.1002756.
   PubMed Web of Science ®Google Scholar
• Goldstein ND, LeVasseur MT, Tran NK, Purtle J, Welles SL, Eppes SC. Modeling HPV vaccination scale-up among urban young men who have sex with men in the context of HIV. Vaccine. 2019;37:3883–91. doi:10.1016/j.vaccine.2019.05.047.
   PubMed Web of Science ®Google Scholar
• Martinez-Gomez X, Curran A, Campins M, Alemany L, Rodrigo-Pendas JA, Borruel N, Castellsague X, Diaz-de-Heredia C, Moraga-Llop FA, Del PM, et al. Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016. Euro Surveill. 2019;24(7):24. doi:10.2807/1560-7917.ES.2019.24.7.1700857.
   Google Scholar
• Kirby T. MSM in England to be offered free HPV vaccination. Lancet Oncol. 2018;19:e148. doi:10.1016/S1470-2045(18)30158-X.
   PubMed Web of Science ®Google Scholar
• Chow EPF, Danielewski JA, Murray GL, Fehler G, Chen MY, Bradshaw CS, Garland SM, Fairley CK. Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia. Vaccine. 2019;37:6271–75. doi:10.1016/j.vaccine.2019.08.066.
   PubMed Web of Science ®Google Scholar
• Loretan C, Chamberlain AT, Sanchez T, Zlotorzynska M, Jones J. Trends and characteristics associated with human papillomavirus vaccination uptake among men who have sex with men in the United States, 2014–2017. Sex Transm Dis. 2019;46(7):465–73. doi:10.1097/OLQ.0000000000001008.
   PubMed Web of Science ®Google Scholar
• Petit B, Epaulard O. Men having sex with men and the HPV vaccine in France: A low vaccine coverage that may be due to its infrequent proposal by physicians. Vaccine. 2020;38:2160–65. doi:10.1016/j.vaccine.2020.01.049.
   PubMed Web of Science ®Google Scholar
• Gerend MA, Madkins K, Phillips G, Mustanski B. Predictors of human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis. 2016;43(3):185–91. doi:10.1097/OLQ.0000000000000408.
   PubMed Web of Science ®Google Scholar
• Cummings T, Kasting ML, Rosenberger JG, Rosenthal SL, Zimet GD, Stupiansky NW. Catching up or missing out? Human papillomavirus vaccine acceptability among 18- to 26-year-old men who have sex with men in a US National sample. Sex Transm Dis. 2015;42(11):601–06. doi:10.1097/OLQ.0000000000000358.
   PubMed Web of Science ®Google Scholar
• Huachun Z, Lin Z, Puifung CE, Lei Z. [Teenage men who have sex with men should be vaccinated against human papillomavirus infection]. Chin J Epidemiol. 2014;35:1072–73.
   Google Scholar
• Zhang Y, Wang Y, Liu L, Fan Y, Liu Z, Wang Y, Nie S. Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies. Bmc Public Health. 2016:16. doi:10.1186/s12889-016-2873-8.
   PubMed Web of Science ®Google Scholar
• Tian T, Wang D, Papamichael C, Yan Z, Guoyao S, Zhanlin Z, Mahan Y, Xiaoqing T, Zheng G, Jianghong D. HPV vaccination acceptability among men who have sex with men in Urumqi, China. Hum Vaccin Immunother. 2019;15(4):1005–12. doi:10.1080/21645515.2018.1520591.
   PubMed Web of Science ®Google Scholar
• Zou H, Meng X, Jia T, Zhu C, Chen X, Li X, Xu J, Ma W, Zhang X. Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: A cross-sectional study. Hum Vacc Immunother. 2016;12:1551–59.
   PubMed Web of Science ®Google Scholar
• Nadarzynski T, Smith H, Richardson D, Bremner S, Llewellyn C. Men who have sex with men who do not access sexual health clinics nor disclose sexual orientation are unlikely to receive the HPV vaccine in the UK. Vaccine. 2018;36:5065–70. doi:10.1016/j.vaccine.2018.06.075.
   PubMed Web of Science ®Google Scholar
• Jingheng H. Health education, 5th ed. Chongqing, China: Fudan University Press; 2011.
   Google Scholar
• Li J, Kang L, Li B, Pang Y, Huang R, Qiao Y. Effect of a group educational intervention on rural Chinese womenʻs knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines. Bmc Cancer. 2015:15. doi:10.1186/s12885-015-1682-2.
   PubMed Web of Science ®Google Scholar
• Zhang S, Pan X, Wang S, Yang C, Gao X, Wang Z, Li M, Ren Z, Zheng Q, Ma W et al. Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: a nationwide survey in China. Ann Epidemiol. 2015;25(4):231–35. doi:10.1016/j.annepidem.2014.12.009.
   PubMed Web of Science ®Google Scholar
• Chang IJ, Huang R, He W, Zhang SK, Wang SM, Zhao FH, Smith JS, Qiao YL. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. Bmc Public Health. 2013;13(1):916. doi:10.1186/1471-2458-13-916.
   PubMed Web of Science ®Google Scholar
• Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Model. 1999;6.
   Web of Science ®Google Scholar
• National Medical Products Administration. The first domestic recombinant human papillomavirus vaccine has been licensed. [accessed 2022 Jan 7]. https://www.nmpa.gov.cn/directory/web/nmpa/yaowen/ypjgyw/20191231160701608.html
   Google Scholar
• Ye Z, Liu Z, Cui S, Chu Z, Jiang Y, Xu J, Hu Q, Shang H. High human papilloma virus vaccine acceptability and cost-effectiveness of the Chinese 2-Valent vaccine among men who have sex with men: a cross-sectional study in Shenyang, China. Front Med. 2021:8. doi:10.3389/fmed.2021.763564.
   Web of Science ®Google Scholar
• Zhao Y, Xin X, Deng H, Xu J, Weng W, Zhang M, Li J, Gao Y, Huang X, Liu C. Improving the acceptability of human papillomavirus vaccines among men who have sex with men according to the associated factors: a systematic review and meta-analysis. Front Pharmacol. 2021:12. doi:10.3389/fphar.2021.600273.
   Web of Science ®Google Scholar
• Sallam M, Al-Mahzoum K, Eid H, Assaf AM, Abdaljaleel M, Al-Abbadi M, Mahafzah A. Attitude towards HPV vaccination and the intention to get vaccinated among female university students in health schools in Jordan. Vaccines. 2021;9:1432. doi:10.3390/vaccines9121432.
   Web of Science ®Google Scholar
• Hu S, Xu X, Zhang Y, Liu Y, Yang C, Wang Y, Wang Y, Yu Y, Hong Y, Zhang X et al. A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China. Vaccine. 2021;39:35–44. doi:10.1016/j.vaccine.2020.11.029.
   PubMed Web of Science ®Google Scholar
• Lin D, Fang X, and Li X. Review of health behavior change theory. Psychol Dev Educ. 2005;04:122–27.
   Google Scholar
• Zhou Y, Lin Y, Meng X, Duan Q, Wang Z, Yang B, Zheng H, Li P, Li M, Lu Y et al. Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination. Vaccine. 2020;38:2849–58. doi:10.1016/j.vaccine.2020.02.009.
   PubMed Web of Science ®Google Scholar
• Nadarzynski T, Smith H, Richardson D, Pollard A, Llewellyn C. Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: A qualitative analysis. Brit J Health Psych. 2017;22(2):345–61. doi:10.1111/bjhp.12233.
   PubMed Web of Science ®Google Scholar